Baseline neurofilament light levels track with brain volume loss in MSOctober 8, 2019Multiple Sclerosis
Continuation of natalizumab treatment reduces risk of MS relapses during pregnancySeptember 24, 2019Multiple Sclerosis
Even with no disease activity, recurrence risk near 50% when stopping DMTs for MSSeptember 17, 2019Multiple Sclerosis
Plasma exchange in natalizumab-related PML shows no benefit, possible harmSeptember 16, 2019Multiple Sclerosis
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomideSeptember 16, 2019Multiple Sclerosis
Ponesimod reduces annualized relapse rate, compared with teriflunomideSeptember 12, 2019Multiple Sclerosis
Continuous treatment reduces risk of confirmed disability progression in MSSeptember 12, 2019Multiple Sclerosis
